Valuation: Virbac

Market Cap 271.86Cr 309.95Cr 251.79Cr 231.68Cr 438.21Cr 30TCr 446.74Cr 3TCr 1.18TCr 15TCr 1.16TCr 1.14TCr 50TCr P/E 2026 *
16x
P/E 2027 * 14.4x
Enterprise Value 283.96Cr 323.75Cr 263Cr 241.99Cr 457.71Cr 31TCr 466.62Cr 3.13TCr 1.23TCr 15TCr 1.22TCr 1.19TCr 53TCr EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.67x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-.--% - - 309.95Cr
-0.22%-0.04%-51.35%-55.91% 3.16TCr
+1.29%+0.04%+68.72%+137.17% 1.26TCr
-1.14%-7.35%-20.31%-2.50% 354.74Cr
-2.87%-7.14%+49.37%+22.85% 190.65Cr
+2.63%+3.48%-25.17%+17.39% 170.82Cr
+2.90%-3.31%+7.14%+124.34% 133.86Cr
+1.41%-1.25%-19.68%-13.81% 105.74Cr
+2.54%+1.68%-6.67%-18.39% 96Cr
+0.49%-3.32%-18.73%-48.35% 92Cr
Average +0.49%-0.79%-1.85%+18.09% 617.85Cr
Weighted average by Cap. +0.10%-0.36%-14.67%+1.96%

Financials

2026 *2027 *
Net sales 154.82Cr 176.51Cr 143.39Cr 131.93Cr 249.55Cr 17TCr 254.4Cr 1.71TCr 670.27Cr 8.3TCr 662.81Cr 648.32Cr 29TCr 164.48Cr 187.52Cr 152.34Cr 140.17Cr 265.12Cr 18TCr 270.28Cr 1.82TCr 712.1Cr 8.81TCr 704.16Cr 688.77Cr 30TCr
Net income 17Cr 19Cr 16Cr 14Cr 27Cr 1.84TCr 28Cr 186.04Cr 73Cr 903.15Cr 72Cr 71Cr 3.12TCr 19Cr 22Cr 18Cr 16Cr 31Cr 2.07TCr 31Cr 209.22Cr 82Cr 1.02TCr 81Cr 79Cr 3.51TCr
Net Debt 12Cr 14Cr 11Cr 10Cr 20Cr 1.32TCr 20Cr 133.56Cr 52Cr 648.38Cr 52Cr 51Cr 2.24TCr 2.65Cr 3.02Cr 2.45Cr 2.26Cr 4.27Cr 289.09Cr 4.35Cr 29Cr 11Cr 141.97Cr 11Cr 11Cr 490.28Cr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA